{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:148123",
      "entity_text" : "docetaxel",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00583",
      "entity_text" : "LC3-II",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "We found that LC3-II expression decreased when PC3 cells had a treatment of docetaxel with pretreatment of SP600125 (10 muM, 30 min).",
  "reading_complete" : "2020-08-05T20:09:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T20:06:52Z",
  "trigger" : "decreased",
  "evidence" : [ "LC3-II expression decreased when PC3 cells had a treatment of docetaxel" ],
  "pmc_id" : "5878207",
  "score" : 0
}